Your browser doesn't support javascript.
loading
Perilla frutescens Leaf Extract Attenuates Vascular Dementia-Associated Memory Deficits, Neuronal Damages, and Microglial Activation.
Kang, Hyun-Bae; Kim, Shin-Hye; Uhm, Sun-Ho; Kim, Do-Kyung; Lee, Nam-Seob; Jeong, Young-Gil; Sung, Nak-Yun; Kim, Dong-Sub; Han, In-Jun; Yoo, Young-Choon; Han, Seung-Yun.
  • Kang HB; Department of Anatomy, College of Medicine, Konyang University, Daejeon 35365, Korea.
  • Kim SH; Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Korea.
  • Uhm SH; Department of Anatomy, College of Medicine, Konyang University, Daejeon 35365, Korea.
  • Kim DK; Department of Anatomy, College of Medicine, Konyang University, Daejeon 35365, Korea.
  • Lee NS; Department of Anatomy, College of Medicine, Konyang University, Daejeon 35365, Korea.
  • Jeong YG; Department of Anatomy, College of Medicine, Konyang University, Daejeon 35365, Korea.
  • Sung NY; Division of Natural Product Research, Korea Prime Pharmacy Co., Ltd., Jeonnam 58144, Korea.
  • Kim DS; Division of Natural Product Research, Korea Prime Pharmacy Co., Ltd., Jeonnam 58144, Korea.
  • Han IJ; Division of Natural Product Research, Korea Prime Pharmacy Co., Ltd., Jeonnam 58144, Korea.
  • Yoo YC; Department of Microbiology, College of Medicine, Konyang University, Daejeon 35365, Korea.
  • Han SY; Department of Anatomy, College of Medicine, Konyang University, Daejeon 35365, Korea.
Curr Issues Mol Biol ; 44(1): 257-272, 2022 Jan 08.
Article en En | MEDLINE | ID: mdl-35723398
ABSTRACT
Vascular dementia (VaD) is characterized by a time-dependent memory deficit and essentially combined with evidence of neuroinflammation. Thus, polyphenol-rich natural plants, which possess anti-inflammatory properties, have received much scientific attention. This study investigated whether Perilla frutescens leaf extract (PFL) exerts therapeutic efficacy against VaD. Sprague Dawley rats were divided into five groups SO, sham-operated and vehicle treatment; OP, operated and vehicle treatment; PFL-L, operated and low-dose (30 mg/kg) PFL treatment; PFL-M, operated and medium-dose (60 mg/kg) PFL treatment; and PFL-H, operated and high-dose (90 mg/kg) PFL treatment. Two-vessel occlusion and hypovolemia (2VO/H) were employed as a surgical model of VaD, and PFL was given orally perioperatively for 23 days. The rats underwent the Y-maze, Barnes maze, and passive avoidance tests and their brains were subjected to histologic studies. The OP group showed VaD-associated memory deficits, hippocampal neuronal death, and microglial activation; however, the PFL-treated groups showed significant attenuations in all of the above parameters. Using lipopolysaccharide (LPS)-stimulated BV-2 cells, a murine microglial cell line, we measured PFL-mediated changes on the production of nitric oxide (NO), TNF-α, and IL-6, and the activities of their upstream MAP kinases (MAPKs)/NFκB/inducible NO synthase (iNOS). The LPS-induced upregulations of NO, TNF-α, and IL-6 production and MAPKs/NFκB/iNOS activities were globally and significantly reversed by 12-h pretreatment of PFL. This suggests that PFL can counteract VaD-associated structural and functional deterioration through the attenuation of neuroinflammation.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Año: 2022 Tipo del documento: Article